Safety and tolerability of the standardized quality house dust mite sublingual immunotherapy tablet in real life: A noninterventional, open-label study

J Allergy Clin Immunol Pract. 2021 Aug;9(8):3221-3223.e5. doi: 10.1016/j.jaip.2021.03.045. Epub 2021 Apr 8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Dermatophagoides
  • Dermatophagoides pteronyssinus
  • Humans
  • Pyroglyphidae
  • Rhinitis, Allergic*
  • Sublingual Immunotherapy*
  • Tablets
  • Treatment Outcome

Substances

  • Antigens, Dermatophagoides
  • Tablets